Food Psych Podcast with Christy Harrison

#323: The Hidden Risks of Weight-Loss Drugs: Behind the GLP-1 Hype with Ragen Chastain

May 8, 2024
Writer and weight-inclusive health/fitness professional Ragen Chastain discusses the risks of GLP-1 drugs for weight loss, conflicts of interest in drug manufacturer influence, the co-opting of weight stigma, and challenges in integrative medicine spaces regarding body size beliefs.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

The Illusion of the "Best Diet"

  • Ragen Chastain's research into finding the "best diet" led her to realize that long-term weight loss is rare.
  • This discovery prompted her 20-year journey into weight science, weight stigma, and healthcare.
INSIGHT

Repackaged Drugs, Exploited Side Effects

  • GLP-1 drugs, intended for type 2 diabetes, cause weight loss as a side effect.
  • Drug companies repackaged these drugs for weight loss, exploiting this side effect.
INSIGHT

Dosage Discrepancy and Side Effects

  • Weight loss treatments use a higher dose of GLP-1 drugs than diabetes treatments, maximizing side effects.
  • These side effects, including thyroid tumors, pancreatitis, and kidney injury, can be fatal.
Get the Snipd Podcast app to discover more snips from this episode
Get the app